This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
It is often claimed that knowledge multiplies so rapidly that nobody can follow it. I believe this is incorrect. At least in science it is not true. The main purpose of science is simplicity and as we understand more things, everything is becoming simpler.
Footnotes
Disclosure: Scientific advisory board/data safety monitoring: Cytokinetics Inc. trial of compound in myasthenia gravis; speaker/travel honoraria: 1) American Academy of Neurology, 2) Myasthenia Gravis Foundation of America; journals: 1) Journal Watch Neurology, 2) Muscle & Nerve, 3) Cochrane Collaboration Neuromuscular Review Group, 4) Neuromuscular Disorders; publishing royalties: 1) Neuromuscular Disease: Evidence and Analysis in Clinical Neurology, Humana Press, 2) BluePrints in Neurology, Lippincott, 3) Field of Vision, Humana Press; consultancies: 1) Cytokinetics, 2) Asubio Pharmaceuticals Inc., 3) AriSLA (Italian ALS Association), 4) Canadian ALS Association; research support government: 1) Food and Drug Administration, 2) NIH; research support associations: 1) Muscular Dystrophy Association, 2) ALS Association; legal consult: 1) Parker Waichmann LLP. Go to Neurology.org for full disclosures.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham